Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.14 - $1.83 $2,482 - $32,453
17,734 Added 101.59%
35,191 $5,000
Q2 2022

Aug 15, 2022

BUY
$1.34 - $2.08 $22,047 - $34,222
16,453 Added 1638.75%
17,457 $28,000
Q1 2022

May 12, 2022

SELL
$1.1 - $2.17 $12,021 - $23,715
-10,929 Reduced 91.59%
1,004 $2,000
Q4 2021

Feb 14, 2022

BUY
$1.99 - $3.1 $23,746 - $36,992
11,933 New
11,933 $24,000
Q2 2021

Aug 16, 2021

SELL
$2.56 - $3.35 $5,322 - $6,964
-2,079 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$2.01 - $5.05 $37,997 - $95,465
-18,904 Reduced 90.09%
2,079 $7,000
Q4 2020

Feb 16, 2021

BUY
$1.89 - $2.55 $34,766 - $46,907
18,395 Added 710.78%
20,983 $44,000
Q3 2020

Nov 16, 2020

BUY
$2.46 - $6.15 $6,366 - $15,916
2,588 New
2,588 $6,000
Q1 2020

May 15, 2020

SELL
$1.87 - $4.47 $12,362 - $29,551
-6,611 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$2.48 - $8.1 $15,549 - $50,787
6,270 Added 1838.71%
6,611 $25,000
Q3 2019

Nov 05, 2019

BUY
$8.22 - $11.2 $1,372 - $1,870
167 Added 95.98%
341 $3,000
Q2 2019

Aug 13, 2019

SELL
$10.05 - $14.25 $70,802 - $100,391
-7,045 Reduced 97.59%
174 $2,000
Q1 2019

May 14, 2019

BUY
$11.82 - $14.48 $62,350 - $76,382
5,275 Added 271.35%
7,219 $92,000
Q4 2018

Feb 14, 2019

BUY
$10.8 - $17.94 $16,351 - $27,161
1,514 Added 352.09%
1,944 $25,000
Q3 2018

Nov 13, 2018

BUY
$10.92 - $18.18 $4,695 - $7,817
430 New
430 $7,000
Q4 2017

Feb 09, 2018

SELL
$8.48 - $12.0 $4,299 - $6,084
-507 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$6.38 - $8.14 $3,234 - $4,126
507
507 $4,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.